Gilteritinib as Post-Transplant Maintenance for AML with Internal Tandem Duplication Mutation of FLT3

Mark J. Levis, Mehdi Hamadani, Brent Logan, Richard J. Jones, Anurag K. Singh, Mark Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L. Uy, Edmund K. Waller, Sumithra Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee Je Kim, Jan Henrik MikeschYuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Nancy L. Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi Bin Chen

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Gilteritinib as Post-Transplant Maintenance for AML with Internal Tandem Duplication Mutation of FLT3'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Agricultural and Biological Sciences